Dissertations / Theses on the topic 'Technology in medicine'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 dissertations / theses for your research on the topic 'Technology in medicine.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Carley, Simon. "Technology enhanced learning in emergency medicine." Thesis, Manchester Metropolitan University, 2018. http://e-space.mmu.ac.uk/621509/.
Full textGötze, Sarah, Daniella Ekström, Forssén Tore Larsson, Eric Sjöö, Frisinger Emma Svanberg, and Linnea Wikström. "Personalized Medicine." Thesis, Uppsala universitet, Institutionen för biologisk grundutbildning, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-444200.
Full textHarris, Heather. "Constructing colonialism : medicine, technology, and the frontier nursing service /." Thesis, This resource online, 1995. http://scholar.lib.vt.edu/theses/available/etd-06102009-063404/.
Full textSchreiner, Terri, and Frances Jackson. "Learning via Paradox: Less / More, Communications / Technology Nursing / Medicine." Digital Commons @ East Tennessee State University, 2005. https://dc.etsu.edu/etsu-works/8475.
Full textPolaha, Jodi, J. Correll, and J. Ellison. "Bringing Technology to Integrated Care." Digital Commons @ East Tennessee State University, 2010. https://dc.etsu.edu/etsu-works/6604.
Full textJones, Willie F. "Development of a cellular fiber spinning technology for regenerative medicine." Connect to this title online, 2006. http://etd.lib.clemson.edu/documents/1173995215/.
Full textLiljedahl, Ulrika. "Microarray Technology for Genotyping in Pharmacogenetics." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4222.
Full textManrai, Arjun Kumar. "Statistical foundations for precision medicine." Thesis, Massachusetts Institute of Technology, 2015. http://hdl.handle.net/1721.1/97826.
Full textCataloged from PDF version of thesis.
Includes bibliographical references.
Physicians must often diagnose their patients using disease archetypes that are based on symptoms as opposed to underlying pathophysiology. The growing concept of "precision medicine" addresses this challenge by recognizing the vast yet fractured state of biomedical data, and calls for a patient-centered view of data in which molecular, clinical, and environmental measurements are stored in large shareable databases. Such efforts have already enabled large-scale knowledge advancement, but they also risk enabling large-scale misuse. In this thesis, I explore several statistical opportunities and challenges central to clinical decision-making and knowledge advancement with these resources. I use the inherited heart disease hypertrophic cardiomyopathy (HCM) to illustrate these concepts. HCM has proven tractable to genomic sequencing, which guides risk stratification for family members and tailors therapy for some patients. However, these benefits carry risks. I show how genomic misclassifications can disproportionately affect African Americans, amplifying healthcare disparities. These findings highlight the value of diverse population sequencing data, which can prevent variant misclassifications by identifying ancestry informative yet clinically uninformative markers. As decision-making for the individual patient follows from knowledge discovery by the community, I introduce a new quantity called the "dataset positive predictive value" (dPPV) to quantify reproducibility when many research teams separately mine a shared dataset, a growing practice that mirrors genomic testing in scale but not synchrony. I address only a few of the many challenges of delivering sound interpretation of genetic variation in the clinic and the challenges of knowledge discovery with shared "big data." These examples nonetheless serve to illustrate the need for grounded statistical approaches to reliably use these powerful new resources.
by Arjun Kumar Manrai.
Ph. D.
Bia, Jesse. "Sunshine technology and dream biology : perceptions of regenerative medicine in Japan." Thesis, University College London (University of London), 2018. http://discovery.ucl.ac.uk/10043354/.
Full textButte, Atul J. "Exploring genomic medicine using integrative biology." Thesis, Massachusetts Institute of Technology, 2004. http://hdl.handle.net/1721.1/33680.
Full textIncludes bibliographical references (p. 215-227).
Instead of focusing on the cell, or the genotype, or on any single measurement modality, using integrative biology allows us to think holistically and horizontally. A disease like diabetes can lead to myocardial infarction, nephropathy, and neuropathy; to study diabetes in genomic medicine would require reasoning from a disease to all its various complications to the genome and back. I am studying the process of intersecting nearly-comprehensive data sets in molecular biology, across three representative modalities (microarrays, RNAi and quantitative trait loci) out of the more than 30 available today. This is difficult because the semantics and context of each experiment performed becomes more important, necessitating a detailed knowledge about the biological domain. I addressed this problem by using all public microarray data from NIH, unifying 50 million expression measurements with standard gene identifiers and representing the experimental context of each using the Unified Medical Language System, a vocabulary of over 1 million concepts. I created an automated system to join data sets related by experimental context.
(cont.) I evaluated this system by finding genes significantly involved in multiple experiments directly and indirectly related to diabetes and adipogenesis and found genes known to be involved in these diseases and processes. As a model first step into integrative biology, I then took known quantitative trait loci in the rat involved in glucose metabolism and build an expert system to explain possible biological mechanisms for these genetic data using the modeled genomic data. The system I have created can link diseases from the ICD-9 billing code level down to the genetic, genomic, and molecular level. In a sense, this is the first automated system built to study the new field of genomic medicine.
by Atul Janardhan Butte.
Ph.D.
Sun, Lizhe. "Value creation through modernizing Chinese medicine." Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/42217.
Full textIncludes bibliographical references (leaves 110-114).
My first hypothesis in this thesis is that there is significant value vested in traditional Chinese medicine that can be captured by converting them into ethical drugs through scientific analysis, screening and validation. Further, holistic treatment is a key difference between traditional Chinese medicine and western-type chemical drugs, which makes Chinese medicine a very valuable category of knowledge. Using mixed formula is a primary method of treatment in Chinese medicine. It is the application of distinctive medical philosophies of Chinese herbal medicines in practices, reflecting the uniqueness and advantages of Chinese medicine. For example, there are 96,592 mixed formula recorded by "Dictionary of Chinese Medicine Mixed Formula" published in 1997. My second hypothesis in this thesis is that value can be created and captured, under the globalization context, from mixed herbal formulas for the mainstream world market with the aid of fingerprint technologies. To enter western markets as officially approved drugs through critical pathways, both scientific and regulatory, Chinese herb drugs must demonstrate sound evidence for safety and efficacy. I address in this thesis one of the central concerns of the pharmaceutical companies and FDA, that is, how quality control and material consistency is assured and how toxicity and drug kinetics of Chinese herbal medicines, either in its raw form, its purified form, its composite extract form or its mixed formula form, may be measured with reasonable scientific certainty and what would be the likely trajectory of further research.
(cont.) My thesis research involves the following aspects: firstly, I characterize, by and through historical review and analysis, the formation of unique Chinese holistic medical philosophy to apply herbal medicines, particularly mixed herbal formulas, to systematically modulate the human body to prevent illnesses, to combat health problems and to restore balanced health; secondly, I performed a comparative study on the regulatory systems between Chinese SFDA and US FDA to provide insights on the trend of harmonic convergence of laws and regulations and challenges going forward, including collection and extrapolation of relevant statistical data; thirdly, I researched emerging fingerprint technologies to address the central issues of standardization, quality control, material consistency, safety and efficacy measurements of Chinese herbal medicines; fourthly, I performed data collection on major Chinese sources of published literatures and patent applications/grants for public and private medicinal knowledge formation, which may be viewed as a surrogate indicator for embedded economic value in the system, to compare trend and gaps between China and developed countries; and lastly, I presented three case studies of development of an-diabetic drugs from herbal sources, to illustrate how value may be created and captured through using modern technologies to tap into the accumulative knowledge base in herbal medicine. The thesis concludes that there are significant values to be captured, by and through cross-border collaborations under the globalization context, from Chinese herbal medicine. Both ethical single molecular entity (singleton) herb-derived drugs and mixed formula herb-derived drugs may be created going forward.
by Lizhe Sun.
S.M.
Flash, Gregory Henry. "Feasibility of using an industrial robot with the LODOX technology." Master's thesis, University of Cape Town, 2002. http://hdl.handle.net/11427/3385.
Full textDebTech Pty(LTD), a subsidiary of De Beers South Africa, has designed a low dosage digital X-ray machine called LODOX. This innovative machine has been commissioned in Groote Schuur Hospital in Cape Town, South Africa. It is capable of performing standard radiological scans, producing high quality images quickly and in a digital form.
Zuiderent-Jerak, Teun. "Standardization healthcare practices; experimental interventions in medicine and science and technology studies." [S.l.] : Rotterdam : [The Author] ; Erasmus University [Host], 2007. http://hdl.handle.net/1765/10605.
Full textCarmel, Simon Harry Michael. "High technology medicine in practice : the organisation of work in intensive care." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2003. http://researchonline.lshtm.ac.uk/682319/.
Full textKachnowski, Stanislaw. "A history of medical technology in post-colonial India : the development of technology in medicine from 1947-1991." Thesis, University of Oxford, 2015. https://ora.ox.ac.uk/objects/uuid:a98170a0-f494-401e-9ad3-4483e89f6359.
Full textChang, Ming-lai Lily. "Innovation and technology development in Hong Kong : infrastructure support for Chinese medicine based industry /." Hong Kong : University of Hong Kong, 2000. http://sunzi.lib.hku.hk/hkuto/record.jsp?B2228493X.
Full textGoren, Amir S. M. Massachusetts Institute of Technology. "Assessing the economic case for stratified medicine." Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/42207.
Full textIncludes bibliographical references (leaves 36-39).
The goal of this study is to explore the economic conditions that favor the joint development of therapeutics and companion diagnostics. I hypothesize that predictive biomarkers can generate economic value in drug development by increasing success rates. I construct an economic model of the development of a hypothetical new therapy, and devote particular attention to parameters regarding safety, efficacy, cost, and market size, within a decision-theoretic framework. The results include a characterization of the dynamic net present value trade-offs between stratum size and biomarker success, as well as the identification of two complementary concepts of stratified medicine, namely, disease reclassification and value-based reimbursement. I also identify a strong potential incentive mechanism in the hands of public policy makers that could facilitate a resolution of the tension between patient interests and the interests of pharmaceutical sponsors. The conclusion is that a biomarker can compensate for smaller stratum by increasing success probabilities. However, the effects of longer development time due to biomarker inclusion counter the effects of improved success probabilities. Longer exclusivity periods for stratified medicine may be required in order to resolve the tension between patient interests and the interests of pharmaceutical sponsors.
by Amir Goren.
S.M.
Polaha, Jodi, J. Shore, C. Turvey, E. Nelson, M. Mishkind, and R. Ciulla. "Transformations in Telemental Health Technology and Policy: Implications for Practice." Digital Commons @ East Tennessee State University, 2012. https://dc.etsu.edu/etsu-works/6687.
Full textLizama, Natalia. "Afterlife, but not as we know it : medicine, technology and the body resurrected." University of Western Australia. School of Social and Cultural Studies, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0186.
Full textChang, Ming-lai Lily, and 張明麗. "Innovation and technology development in Hong Kong: infrastructure support for Chinese medicine basedindustry." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2000. http://hub.hku.hk/bib/B31260202.
Full textCheah, Boon Chong. "Metabolomic sensing system for personalised medicine using an integrated CMOS sensor array technology." Thesis, University of Glasgow, 2017. http://theses.gla.ac.uk/8115/.
Full textMcKay, Terri L. "A CFD Model of Mixing in a Microfluidic Device for Space Medicine Technology." Cleveland State University / OhioLINK, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=csu1305563573.
Full textHunter, Morris. "The development of a baccalaureate degree program in medical imaging technology." CSUSB ScholarWorks, 1999. https://scholarworks.lib.csusb.edu/etd-project/1857.
Full textFredriksson, Mona. "Using Minisequencing Technology for Analysing Genetic Variation in DNA and RNA." Doctoral thesis, Uppsala University, Department of Medical Sciences, 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4789.
Full textIn this thesis, the four-color fluorescence tag-microarray minisequencing system pioneered by our group was further developed and applied for analysing genetic variation in human DNA and RNA. A SNP marker panel representing different chromosomal regions was established and used for identification of informative SNP markers for monitoring chimerism after stem cell transplantation (SCT). The success of SCT was monitored by measuring the allelic ratios of informative SNPs in follow-up samples from nine patients with leukaemia. The results agreed with data obtained using microsatellite markers. Further the same SNP marker panel was used for evaluation of two whole genome amplification methods, primer extension preamplification (PEP) and multiple displacement amplification (MDA) in comparison with genomic DNA with respect to SNP genotyping success and accuracy in tag-array minisequencing. Identical results were obtained from MDA products and genomic DNA.
The tag-microarray minisequencing system was also established for multiplexed quantification of imbalanced expression of SNP alleles. Two endothelial cell lines and a panel of ten coding SNPs in five genes were used as model system. Six heterozygous SNPs were genotyped in RNA (cDNA) from the cell lines. Comparison of the relative amounts of the SNPs alleles in cDNA to heterozygote SNPs in genomic DNA displayed four SNPs with significant imbalanced expression between the SNP alleles. Finally, the tag-array minisequencing system was modified for detection of splice variants in mRNA from five leukaemia cell lines. A panel of 20 cancer-related genes with 74 alternatively splice variants was screened. Over half of the splice variants were detected in the cell lines, and similar alternative splicing patterns were observed in each cell line. The results were verified by size analysis of the PCR product subjected to the minisequencing primer extension reaction. The data from both methods agreed well, evidencing for a high sensitivity of our system.
Harvey, Janet. "Behind the medical mask : medical technology and medical power." Thesis, University of Warwick, 1992. http://wrap.warwick.ac.uk/36139/.
Full textArafat, Basel. "Proliposome technology for protein delivery." Thesis, University of Central Lancashire, 2013. http://clok.uclan.ac.uk/9633/.
Full textGonzales, Dominic V. "An analysis of automated solutions for the Certification and Accreditation of navy medicine information assets." Thesis, Monterey, Calif. : Springfield, Va. : Naval Postgraduate School ; Available from National Technical Information Service, 2005. http://library.nps.navy.mil/uhtbin/hyperion/05Sep%5FGonzales.pdf.
Full textWebber, Nicholas R. "Technology and Commercial Assessment of a Tissue Regenerating Drug in the Regenerative Medicine Market." Case Western Reserve University School of Graduate Studies / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=case1402249985.
Full textWick, Livia. "Making lives under closure : birth and medicine in Palestine's waiting zones." Thesis, Massachusetts Institute of Technology, 2006. http://hdl.handle.net/1721.1/38205.
Full textIncludes bibliographical references (p. 254-262).
Reproduction is a site for understanding the ways in which people reconceptualize and re-organize the world in which they live. This dissertation tries to understand the world of birth under the regime of closures and fragmentation that governs the lives of Palestinians. It describes how checkpoints, closures, curfews have come to characterize childbirth in Palestine. It illustrates how the changing infrastructure, economy and discourse around birth produce new experiences of life in the medical sphere and in a family. Oral histories, life histories, doctors', midwives' and mothers' accounts, news reports and literature speak of these new conditions and experiences of birth and life. The meanings and structures of medicine, family and motherhood are thus remade. Oral histories focus on a history of the health infrastructure and movements in medicine, in particular the sumud (steadfastness) movement and the popular health movement. They illustrate how the figure of the doctor overlaps with that of the political leader. They identify the new health infrastructures built to assist birth during the closure which have different politics than the earlier movements, marking the post-socialist age, but show remarkable continuities with them in their emergence, mobilization and hierarchies. These new infrastructures, economies and discourses produce changing stories about birth and changing subjects. I identify two genres of birth stories, the first, narrated by mothers and the second, collected from newspapers. The former is in the register of the ordinary. The mothers remember the space of the hospital, a socio-economic space signaling class, as well as the trip from home to hospital and back. The stories seem uncanny. Occupation, closures and warfare are simply part of the ordinary. By contrast, the newspaper birth stories are sensational. They tell of checkpoint and prison births, occupation, suffering and resistance. They speak of miraculous redemption but in opposition to mothers' narrations, they are familiar. Finally, listening to the inner worlds of birth-mothers under the impress of economic, political and domestic pressures this dissertation distinguishes "enclosure" as a worldview caused by occupation and family relations, thus re-evaluating meanings of family, motherhood and life.
by Livia Wick.
Ph.D.in History, Anthropology, and Science, Technology and Society (HASTS
Govender, Katya. "A pharmacokinetic and efficacy study of Lumefantrine in mice: evaluating the application of Pheroid™ technology." Master's thesis, University of Cape Town, 2012. http://hdl.handle.net/11427/3393.
Full textKegley, John K. "Understanding the Use of Online Health Information Technology byPeople with and without Visual Disabilities." Wright State University / OhioLINK, 2016. http://rave.ohiolink.edu/etdc/view?acc_num=wright1470918391.
Full textHolland, Chad D. (Chad Darrel). "Personalized medicine, population genetics and privacy : an empirical study of international gene banks." Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/33089.
Full textIncludes bibliographical references.
The promise of personalized medicine lies in its potential to fundamentally change healthcare. In the past, pharmaceuticals were prescribed on a "one size fits all" basis-patients with certain disease phenotypes were given what were thought to be appropriate drugs. There is growing evidence however that the effectiveness of these drugs may differ by individual and by sub-group; presumably due to fundamental genetic differences in disease and metabolic pathways. Drugs like Herceptin, Gleevec and Iressa are part of an emerging trend in the biopharmaceutical arena of drugs that are accompanied by genetic diagnostic tests and prescribed only for patients with genotypes in which the agents are most effective.
by Chad D. Holland.
S.M.M.O.T.
S.M.
Arwady, M. Allison. "The uses of rickets race, technology, and the politics of preventive medicine in the early twentieth century /." [New Haven, Conn. : s.n.], 2008. http://ymtdl.med.yale.edu/theses/available/etd-11172008-140502/.
Full textSingh, Pawanbir. "Enabling late-stage translation of regenerative medicine based products." Thesis, Loughborough University, 2010. https://dspace.lboro.ac.uk/2134/6060.
Full textSampalis, Fotini. "Microinvasive technology for the diagnosis and staging of breast cancer." Thesis, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=102723.
Full textDesign. The thesis consists of two observational studies. The first study was partially retrospective and partially prospective. The second study was prospective. The research was conducted between September 1997 and December 2001.
Methods. For the first study 262 women with non-palpable mammographic abnormalities were enrolled. Of these, 260 women underwent an ABBI. The ABBI procedure was performed by 3 surgeons in two hospitals in Montreal. The files of 531 women with similar findings who underwent a wire localization excisional biopsy in the same hospitals by the same surgeons were retrospectively reviewed. Data obtained included technical success, macroscopic and microscopic clarity of margins, need for supplemental surgery and residual cancer, volume of breast tissue excised, patient satisfaction, surgeon volume-performance association and health care costs.
For the second study, 110 women with confirmed operable primary breast cancer who required axillary lymph node dissection were enrolled. All the patients underwent two lymphoscintigraphies. The first (preliminary) lymphoscintigraphy took place at least 2 weeks before surgery and the second (preoperative) took place 2-24 hours before surgery. For the preliminary lymphoscintigraphy, 47 (42.7%) of the 110 women were tested with 99mTechnetium Sestamibi and 63 (57.3%) were tested with 99mTechnetium Sulphur Colloid. For the preoperative lymphoscintigraphy all patients were tested with 99mTechnetium Sulphur Colloid. All patients underwent axillary lymph nodes dissection. The data reviewed was the presence of metastasis in the axillary lymph nodes excised and the lymphoscintigraphy gamma camera imaging and gamma probe digital outcomes. The ROC curve was used to define the most probable cut-off points for the distinction between gamma counts representing positive and negative for metastasis axillary lymph nodes.
Results. For the first study, diagnostic effectiveness of the ABBI was 99.6% and the mean volume of excised breast tissue was 40cc. No serious complications were reported. For wire localization, the diagnostic effectiveness was 98.0% and the mean volume of excised breast tissue was 102cc. severity of complications was similar between the two techniques. The therapeutic effectiveness of the ABBI was 76.3%, supplementary surgery was required in 27.6% of the patients, and residual cancer was detected in 23.8%. The therapeutic effectiveness of wire localization biopsy was 47.0%, 53% of the patients underwent supplementary surgery and residual tumor was found in 48.0%. Of the 260 patients who underwent an ABBI, 51% reported a good level of satisfaction and 23% reported excellent. A significant association was shown between volume and therapeutic effectiveness for all 3 surgeons. On the average, the ABBI resulted in a cost reduction of $5,352 CAD (2000).
For the second study, the sensitivity of 99mTechnetium Sestamibi lymphoscintigraphy imaging was 50%, the negative predictive value was 83.8% and the proportion of false negative results was 17.1%. Logistic regression showed a statistically significant (p<0.001) association between the gamma probe counts and axillary lymph node metastasis. Using 3,080 counts as cut-off point on the ROC curve the sensitivity and false negative rate were 100%, the specificity was 94.3%, and the positive predictive value was 83.3%.
Conclusion. The results of the first study show that the ABBI offers a safe and well tolerated microinvasive surgical technique, with superior therapeutic effectiveness, less invasiveness, and better cost effectiveness than wire localization excisional biopsy. The strong volume-performance association shows that the therapeutic effectiveness of the ABBI can improve with proper training and experience.
The results of the second study show that 99mTechnetium Sestamibi lymphoscintigraphy imaging was 50% the negative predictive value was 83.8% and the proportion of false negative results was 17.1%. A significant association was shown between the intensity of radioactivity in the hot node as measured by the gamma-probe counts and the presence of axillary lymph node metastasis.
In conclusion, this thesis demonstrates that both the ABBI and lymphoscintigraphy with 99mTechnetium Sestamibi are superior to conventional techniques used for the management of mammographic abnormalities and specifically breast cancer. Proper training of surgeons in highly qualified training centers with a high volume of cases can help further improve the effectiveness and increase the practise of these techniques in Canadian hospitals. This may in turn increase the benefits for the patients and reduce the healthcare costs for the management of breast disease and specifically breast cancer in Canada.
Lindroos, Katarina. "Accessing Genetic Variation by Microarray Technology." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2002. http://publications.uu.se/theses/91-554-5251-5/.
Full textEljaaidi, Abdalla Agila. "2D & 3D ultrasound systems in development of medical imaging technology." Thesis, Cape Peninsula University of Technology, 2016. http://hdl.handle.net/20.500.11838/2193.
Full textUltrasound is widely used in most medical clinics, especially obstetrical clinics. It is a way of imaging methods that has important diagnostic value. Although useful in many different applications, diagnostic ultrasound is especially useful in antenatal (before delivery) diagnosis. The use of two-dimensional ultrasound (2DUS) in obstetrics has been established. However, there are many disadvantages of 2DUS imaging. Several researchers have published information on the significance of patients being shown the ultrasound screen during examination, especially during three- and four-dimensional (3D/4D) scanning. In addition, a form of ultrasound, called keepsake or entertainment ultrasound, has boomed, particularly in the United States. However, long-term epidemiological studies have failed to show the adverse effects of ultrasound in human tissues. Until now, there is no proof that diagnostic ultrasound causes harm in a human body or the developing foetus when used correctly. While ultrasound is supposed to be absolutely safe, it is a form of energy and, as such, has effects on tissues it traverses (bio-effects). The two most important mechanisms for effects are thermal and non-thermal. These two mechanisms are indicated on the screen of ultrasound devices by two indices: The thermal index (TI) and the mechanical index (MI). These are the purposes of this thesis: • evaluate end-users’ knowledge regarding the safety of ultrasound; • evaluate and make a comparison between acoustic output indices (AOI) in B-mode (2D) and three-dimensional (3D) ultrasound – those measured by thermal (TI) and mechanical (MI) indices; • assess the acoustic output indices (AOI) to benchmark current practice with a survey conducted by the British Medical Ultrasound Society (BMUS); and • review how to design 2D and 3D arrays for medical ultrasound imaging
Ramsey, Michael W. "Physiological Technology for Coaches." Digital Commons @ East Tennessee State University, 2012. https://dc.etsu.edu/etsu-works/4105.
Full textMatanzima, Yonela. "Quantitative and qualitative optimization of antimicrobial bioactive constituents of Helichrysum cymosum using hydroponics technology." Thesis, Cape Peninsula University of Technology, 2014. http://hdl.handle.net/20.500.11838/849.
Full textThe high demand for medicinal plants has favoured over-exploitation of wild plants. The search for alternative and sustainable methods of medicinal plant cultivation is imperative and desirable. Biotechnological approaches particularly hydroponic technology has the potential for large scale plant cultivation and production of secondary metabolites. The current study aims at optimizing the production of antimicrobial secondary metabolites by an indigenous South African medicinal plant species (Helichrysum cymosum) through hydroponics N and K fertilization. In Chapter 1, the conceptual framework and justifications of the study are presented. In Chapter 2 the research objective was to discern the optimal potassium (K) supplement level for H. cymosum by evaluating the effects of different hydroponic K levels on growth, K-leaf content, and anti-Fusarium oxysporum f.sp.glycines (Ascomycota: Hypocreales) and total activities. Six weeks old seedlings of H. cymosum were treated with varied concentrations of K in the form of potassium chloride, potassium nitrate and monopotassium phosphate (58.75, 117.5, 235 and 470 ppm). These concentrations were based on a modification of Hoagland’s hydroponic nutrient formula. Plants were maintained under greenhouse conditions and growth parameters (plant height and number of leaves) were recorded weekly. At 8 weeks post treatment, plants were harvested and fresh weights were recorded and tissue nutrient content analysed. Sub-samples of the aerial parts of plants grown in the different treatments were air dried, extracted with acetone and tested against F. oxysporum. Plants exposed to 235 ppm K showed a marked increase in leaf number, plant height and fresh weight. Overall there was no significant difference (P > 0.05) among the treatments with respect to tissue nutrient content; K ranged from 3.56 ± 0.198 to 4.67 ± 0.29 %. The acetone extraction yield increased with increasing K fertilization: 58.75 ppm (16.67 ± 2.35 mg), 117.5 ppm (22.5 ± 4.79 mg), 235 ppm (210 ± 38.5 mg) but dropped to 40 ± 4.08 mg at 470 ppm K. Results from the anti-F. oxysporum bioassay showed that 58.75 and 235 ppm K treatments produced the most bioactive acetone extracts; MIC values of 0.49 and 0.645 mg/l, respectively. Acetone extracts obtained from plants exposed to 235 ppm K yielded the highest total activity, comparatively (P < 0.05). In conclusion, the optimum nutrient K level for growing H. cymosum hydroponically was 235 ppm. Chapter 3 focused on another important macro nutrient N and the objective was to determine the optimum nutrient requirements for growing the medicinal plant, Helichrysum cymosum (L.) (Asteraceae), hydroponically. Experiments were conducted to assess the effects of varied nitrogen (N) concentrations supplied as nitrate and ammonium on growth, tissue nutrient content, antimicrobial and total activities of acetone extracts of aerial parts. Treatments were based on a modified Hoagland’s nutrient formula. Six week old rooted cuttings were treated with 52.5 ppm, 105 ppm, 210 ppm and 420 ppm of N. Leaf number and stem height (cm) were recorded at weekly intervals and leaf analysis conducted. The effects of N treatments on plant growth parameters varied significantly among treatments; 52.5 ppm of N yielded the tallest plants (height) [19.4 ± 0.7 cm], while 105 ppm N yielded the maximum leaf number (68.1 ± 6.2) as well as maximum fresh weight of aerial parts was obtained with 105 ppm (15.12 ± 1.68 g). Nitrogen content of plant tissue ranged between 0.53 ± 0.03 and 4.74 ± 0.29% (d, f, 3, 12; f=14; P ≤ 0.002) depending on treatments. Powdered aerial parts (5 g) of H. cymosum obtained from the different N treatments were extracted with 100 ml of acetone. N treatment significantly affected the yield of crude extracts, which ranged from 87.5 ± 15.5 (52.5 ppm) to 230 ± 23.5 mg (105 ppm). Acetone extracts of plants that were exposed to varied N treatments were screened for anti-Fusarium oxysporum activity using minimum inhibitory concentration (MIC) method. The MIC value (0.073 ± 0.014 mg/ml) obtained with acetone extracts of plants exposed to 52.5 ppm N was significantly lower compared to the MICs of the other N treatments (105 [0.47 ± 0 and 0.705 ± 0.135 mg/ml], 210 [0.234 and 0.47 mg/ml] and 420 ppm [0.29 ± 0.101 mg/ml]) at 24 and 48 hours respectively. However, the total activities of extracts obtained among the four N treatments, which ranged from 0.062 ± 0.02 to 0.26 ± 0.06 ml/g was not statistically different at 24 or 48 hours (P > 0.05). LC-MS analysis of acetone extracts of H. cymosum plants obtained from the four treatments hinted that known anti-microbial agents such as apigenin, quercetin, kaempferol, helihumulone and quinic acids were present in the extracts and the quantity of helihumulone increased with increased nutrient N level. These results suggest that H. cymosum may be cultivated hydroponically and that the antimicrobial activity and/or the phytochemical profile of the crude acetone extracts is affected by nutrient nitrogen levels. Hydroponic cultivation of plants may be able to alleviate to an extent the pressure on wild medicinal plants.
胡元佳. "Pharmaceutical patent valuation based on technology innovation and applications in the industry." Thesis, University of Macau, 2009. http://umaclib3.umac.mo/record=b2150641.
Full textPeavler, Cheyenne, and Jodi Polaha. "Nature Connectivity in Young Adults: Relationships Between Well-Being, Technology, and the Natural Environment." Digital Commons @ East Tennessee State University, 2011. https://dc.etsu.edu/etsu-works/6635.
Full textMoss, R. "Using assistive technology software to compensate for writing and reading impairments in aphasia." Thesis, City, University of London, 2017. http://openaccess.city.ac.uk/17926/.
Full textLilly, C., and Jodi Polaha. "Technology Use in Rural Appalachia: A Pilot Study of the Implications for Pediatric Behavioral Health." Digital Commons @ East Tennessee State University, 2013. https://dc.etsu.edu/etsu-works/6591.
Full textGetz, Linn. "Sustainable and responsible preventive medicine : Conceptualising ethical dilemmas arising from clinical implementation of advancing medical technology." Doctoral thesis, Norwegian University of Science and Technology, Faculty of Medicine, 2006. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-750.
Full textBackground and setting Health care has become one of the most expansive activities in contemporary societies, and technology is one of its most influential factors. The modern medical-technological enterprise is however facing unprecedented practical, ethical and epistemic challenges. This thesis arises from a well-founded concern that medicine in general, and individually targeted preventive medicine in particular, may be about to become technified and dehumanised to an extent where its integrity and therapeutic as well as preventive potential may deteriorate.
Aims The paramount objective of this project is to contribute to critical reflection and theory building in medicine by performing a systematic documentation, analysis and conceptualisation of possible unacknowledged ethical dilemmas arising from implementation of advancing, preventive, individually targeted medical technology in clinical practice. A secondary aim is to present “sustainable and responsible development” as a potential framework for addressing ethical and practical challenges of this kind.
Theory, methods, and material Medicine is a moral enterprise. Thisrenders all medical research and practice basically value-laden activities. The important implications of this fact are currently not fully recognised among medical researchers and clinicians. This thesis represents an integration of five different studies into a theoretical reflection concerning the inevitable and partly neglected value-ladenness of medicine. According to this position and following the tradition of the humanities, the researcher’s frame of references is presented first, indicating the perspectives from where she wants her work to be regarded. The argument departs from the definitions and goals of medicine and comprises six fields of knowledge relevant for a theoretical exploration of the these goals: the concept of ‘health’; the nature of medical knowledge and ‘evidence’; the notion of ‘medical ethics’; the characteristics of medical technology; and finally, the topics ‘professional responsibility’ and ‘sustainable development’. The studies together address three distinct areas of clinical practice: ultrasound screening for chromosomal aberrations in the fetus, cardiovascular disease prevention in clinical practice, and the consultation in primary health care.
Results All five studies in this thesis demonstrate that implementation of new, preventive medical technology at the interface between individually and population-oriented care can bring forth important and complex ethical dilemmas and even harmful consequences. The results of the papers can be condensed under the following headings: 1. issues related to the theoretical foundation of contemporary, individually based, preventive medicine; 2. topics inherent to applying evidence-based medicine to individual patients; 3. issues related to practical sustainability and the carrying capacity of the healthcare system; and 4. issues of professional responsibility for both knowledge production and implementation of research findings in clinical practice, – the latter heading representing a meta-perspective.
Discussion The results of the five papers are introduced and discussed with reference to teachings and concepts originating from philosophers and medical scholars, such as Martin Heidegger, Hans Jonas, Michel Foucault, Charles Taylor, John Rawls, Arthur Frank, Drew Leder, Ian McWhinney and Eric Cassell. Furthermore, the findings are discussed within a framework that outlines a series of prerequisites for a sustainable and responsible preventive medicine:
- A balanced theoretical approach to medical practice implies that a comprehensive body of medical knowledge about the human condition must build upon both the natural sciences and the humanities.
- Environmental precaution means, in this context, that potential detrimental side-effects of medical activities must be systematically anticipated, supervised and kept at a minimum.
- Equity addresses, in this context, the importance of keeping a sound balance between doctor-initiated, technological preventive activities aiming at ‘population care’ and medical activities that are directed by the expressed problems, concerns or wishes of people seeking care or advice.
- Democratic goal-setting, participation and policy integration mean that all relevant stakeholders should be involved in defining, coordinating and evaluating the overall vision, philosophy and strategies of preventive medicine. Preventive recommendations in particular areas need to be harmonised and prioritised in accordance with an overall vision, and the expected impact of new recommendations on clinical practice should be estimated before guidelines are issued.
- Planning for the future means, in the current context, that we should remember that our priorities and actions ought to appear justifiable and reasonable, not only from the point of view of evidence-based medicine as it appears here and now, but also as regarded from a more distant or even global perspective, or by the generations that will follow us who are making medical reality today. To achieve this, we need to continuously consider to what extent the scientific questions we ask and the decisions we make as professionals are concordant with what rings true and is important to us as fellow human beings.
Key messages and implications The knowledge foundation of modern preventive medicine, targeting individual persons/patients in the context of the traditional clinical encounter, is currently too limited and thus an inadequate basis for clinical action. Ethical deliberation regarding the medical activities explored in this thesis has also been deficient.Despite the medical profession’s explicit intention of doing good, these two fundamental shortcomings imply a potential for inflicting medical harm. This inherent danger imposes the imperative of a paramount responsibility on medical researchers, administrators and practitioners. The practical and ethical impact of technological innovations in preventive medicine should be subjected to systematic and comprehensive analysis. Each particular new technology ought to be evaluated as for its own characteristics and consequences. It should also be measured against the overall goals, means and priorities of preventive medicine. These ought to be clearly defined and made accessible to critical scrutiny and open debate.
Ahmed, Shehnaz. "Self-reporting scaffolds for in situ monitoring for regenerative medicine and tissue engineering applications." Thesis, University of Nottingham, 2018. http://eprints.nottingham.ac.uk/49511/.
Full textMacleod, Marion. "The role of science and technology in the process of medical specialisation." Thesis, University of Edinburgh, 1985. http://hdl.handle.net/1842/19964.
Full textMaitland, Julie. "From persuasion to negotiation in health promoting technology." Thesis, University of Glasgow, 2009. http://theses.gla.ac.uk/808/.
Full textCassa, Christopher A. "Privacy and identifiability in clinical research, personalized medicine, and public health surveillance." Thesis, Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/45624.
Full textThis electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.
Includes bibliographical references (p. 191-200).
Electronic transmission of protected health information has become pervasive in research, clinical, and public health investigations, posing substantial risk to patient privacy. From clinical genetic screenings to publication of data in research studies, these activities have the potential to disclose identity, medical conditions, and hereditary data. To enable an era of personalized medicine, many research studies are attempting to correlate individual clinical outcomes with genomic data, leading to thousands of new investigations. Critical to the success of many of these studies is research participation by individuals who are willing to share their genotypic and clinical data with investigators, necessitating methods and policies that preserve privacy with such disclosures. We explore quantitative models that allow research participants, patients and investigators to fully understand these complex privacy risks when disclosing medical data. This modeling will improve the informed consent and risk assessment process, for both demographic and medical data, each with distinct domain-specific scenarios. We first discuss the disclosure risk for genomic data, investigating both the risk of re-identification for SNPs and mutations, as well as the disclosure impact on family members. Next, the deidentification and anonymization of geospatial datasets containing information about patient home addresses will be examined, using mathematical skewing algorithms as well as a linear programming approach. Finally, we consider the re-identification potential of geospatial data, commonly shared in both textual form and in printed maps in journals and public health practice. We also explore methods to quantify the anonymity afforded when using these anonymization techniques.
by Christopher A. Cassa.
Ph.D.
Chakravorty, Indranil. "Health technology assessment of continuous positive airway pressure devices in sleep apnoea hypopnoea syndrome." Thesis, University of Warwick, 2005. http://wrap.warwick.ac.uk/38056/.
Full textDemopoulos, Pantelis. "Optimising the use of GPS technology to quantify biomechanical load in elite level soccer." Thesis, Edge Hill University, 2016. http://repository.edgehill.ac.uk/8292/.
Full text